US OptionsDetailed Quotes

KZIA240719C1000

Watchlist

0.25
-2.40-90.57%

15min DelayClose Jul 12 16:00 ET

2.65High0.10Low

Kazia Therapeutics Stock Discussion

Sign in to post a comment

Therapeutics Company Announces Clinical Trial Results For Glioblastoma Treatment

Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma.
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...

$Kazia Therapeutics(KZIA.US)$ okay i double down next week

$Kazia Therapeutics(KZIA.US)$ Let's Go Kazia!!!

1

$Kazia Therapeutics(KZIA.US)$ Gettimg back on!

1

4

$Kazia Therapeutics(KZIA.US)$ pump 🙏🙏🙏

1

So quiet compared to yesterday

$Kazia Therapeutics(KZIA.US)$

1

$Kazia Therapeutics(KZIA.US)$ need a break through on this 9.68 resistance ...should fly a bit if so

Buy Rating on Kazia Therapeutics Backed by Promising GBM Study Results and Strong Financial Valuation

$Kazia Therapeutics(KZIA.US)$ only low cuz its being ultra-shorted. we need a squeeze and ghis mother flies 🚀🚀🚀🚀

1

2

Why no movement tonight

$Kazia Therapeutics(KZIA.US)$

6

$Kazia Therapeutics(KZIA.US)$ 1.50 soon

2

2

No comment yet